Risk Of Outcomes Ruled-Out For Measles Vaccines

by Julia Samuel on  January 9, 2015 at 1:53 PM Clinical Trials News
RSS Email Print This Page Comment bookmark
Font : A-A+

Seizure, fever, and immune thrombocytopenia purpura (ITP) are the types of adverse events associated with vaccines for measles.
Risk Of Outcomes Ruled-Out For Measles Vaccines
Risk Of Outcomes Ruled-Out For Measles Vaccines

An investigation was done to check whether the measles-mumps-rubella-varicella (MMRV) is riskier than the separate measles-mumps-rubella (MMR) and varicella (MMR + V) and if it elevates the risk for additional safety outcomes.

Study children were aged 12 to 23 months in the Vaccine Safety Datalink from 2000 to 2012. The number of doses evaluated for MMRV was 123 200 and 584 987 for MMR + V respectively.

Seven outcomes (anaphylaxis, ITP, ataxia, arthritis, meningitis/encephalitis, acute disseminated encephalomyelitis, and Kawasaki disease) were analysed and compared with the vaccines.

There was no significant difference between MMRV with MMR + V as the outcomes had few or zero post vaccination events.

The study did not identify any new safety concerns comparing MMRV with MMR + V or after either the MMRV or the MMR + V vaccine.

The study reassures that these outcomes are unlikely after either vaccine.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Measles Vaccination for Children Rashes Symptom Evaluation 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...